Title |
Vaccines for measles, mumps and rubella in children
|
---|---|
Published in |
Cochrane database of systematic reviews, February 2012
|
DOI | 10.1002/14651858.cd004407.pub3 |
Pubmed ID | |
Authors |
Vittorio Demicheli, Alessandro Rivetti, Maria Grazia Debalini, Carlo Di Pietrantonj |
Abstract |
Mumps, measles and rubella (MMR) are serious diseases that can lead to potentially fatal illness, disability and death. However, public debate over the safety of the trivalent MMR vaccine and the resultant drop in vaccination coverage in several countries persists, despite its almost universal use and accepted effectiveness. |
Twitter Demographics
The data shown below were collected from the profiles of 495 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 89 | 18% |
United Kingdom | 61 | 12% |
Spain | 17 | 3% |
Canada | 14 | 3% |
Australia | 8 | 2% |
Netherlands | 7 | 1% |
Italy | 5 | 1% |
France | 5 | 1% |
Germany | 4 | <1% |
Other | 58 | 12% |
Unknown | 227 | 46% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 395 | 80% |
Practitioners (doctors, other healthcare professionals) | 51 | 10% |
Scientists | 27 | 5% |
Science communicators (journalists, bloggers, editors) | 21 | 4% |
Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 521 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 5 | <1% |
Canada | 2 | <1% |
Spain | 2 | <1% |
Ireland | 1 | <1% |
Australia | 1 | <1% |
Brazil | 1 | <1% |
Italy | 1 | <1% |
South Africa | 1 | <1% |
India | 1 | <1% |
Other | 6 | 1% |
Unknown | 500 | 96% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 107 | 21% |
Student > Master | 92 | 18% |
Researcher | 62 | 12% |
Student > Ph. D. Student | 43 | 8% |
Other | 31 | 6% |
Other | 83 | 16% |
Unknown | 103 | 20% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 202 | 39% |
Nursing and Health Professions | 48 | 9% |
Agricultural and Biological Sciences | 24 | 5% |
Psychology | 21 | 4% |
Social Sciences | 20 | 4% |
Other | 86 | 17% |
Unknown | 120 | 23% |
Attention Score in Context
This research output has an Altmetric Attention Score of 648. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2023.
All research outputs
#31,526
of 24,546,092 outputs
Outputs from Cochrane database of systematic reviews
#63
of 12,930 outputs
Outputs of similar age
#106
of 259,543 outputs
Outputs of similar age from Cochrane database of systematic reviews
#3
of 216 outputs
Altmetric has tracked 24,546,092 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,930 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 34.7. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 259,543 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 216 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 99% of its contemporaries.